3.01 Risk of COVID-19 Among Users of PPIs, Time to Treatment Initiation, & Dr. Lynora Saxinger

OncologyMedicineHealth Policy
Written By Kerrington .

This week we discuss recent research (and the accompanying Twitter thread) on the risk of COVID-19 among users of proton pump inhibitors (PPIs). We also hold a philosophical discussion on the research surrounding time to treatment initiation (TTI) in cancer medicine. We end the episode with an interview with Dr. Lynora Saxinger of the University of Alberta, Edmonton, a specialist in Infectious Diseases.

Kerrington .
Previous

3.02 BONUS! National Clinician Scholars Program with Dr. Hilary Seligman
Next

2.60 BONUS! Cancer Meta-Research 101: The Lay of the Land of Cancer Research